• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤分期和肾切除术对肾癌中CD62P表达及可溶性P选择素浓度的影响

Effect of tumor stage and nephrectomy on CD62P expression and sP-selectin concentration in renal cancer.

作者信息

Mantur M, Kemona H, Kozłowski R, Kemona-Chetnik I

机构信息

Department of Laboratory Diagnostics, Medical Academy of Bialystok, Bialystok, 15-274 Poland.

出版信息

Neoplasma. 2003;50(4):262-5.

PMID:12937838
Abstract

The CD62P receptor and its soluble form sP-selectin is a marker of platelet (PLT) activation, and constitutes a ligand for CD24 antigen of neoplastic cells and tumor stroma components. The aim of the study was to evaluate the relationship dynamics of the percentage of CD62P+ platelets, the level of the receptor expression and the concentration of soluble form of sP-selectin in renal cancer. Examinations were performed before and after nephrectomy in patients with renal cancer (group A - 25, T2N0M0; group B - 27, T2N1-2M0) and in control group (C - 24 subjects). The two groups A and B showed an increased subpopulation of CD62P+ platelets (p<0.01) and elevated sP-selectin concentration (p<0.001) before and after nephrectomy. Although following nephrectomy sP-selectin concentration decreased markedly, it was still higher 3 months after the procedure compared to control group (p<0.05). Following nephrectomy, however, no statistically significant differences were found in the % of CD62P+ platelets and the receptor expression. Greater dynamics of changes before and after nephrectomy in the percentage of CD62P+ platelets (B1:B2 p<0.05) and the receptor expression (B1:B3 p<0.001) was observed in patients with local lymph node involvement (group B) while sP-selectin concentration was similar in both groups. Nephrectomy did not normalize intravascular activation of PLT and TNM had no significant effect on the expression of CD62P and concentration of sP-selectin.

摘要

CD62P受体及其可溶性形式sP-选择素是血小板(PLT)活化的标志物,并且构成肿瘤细胞和肿瘤基质成分的CD24抗原的配体。本研究的目的是评估肾癌中CD62P +血小板百分比、受体表达水平和sP-选择素可溶性形式浓度之间的关系动态变化。对肾癌患者(A组-25例,T2N0M0;B组-27例,T2N1-2M0)和对照组(C组-24名受试者)在肾切除术前和术后进行检查。A组和B组在肾切除术前和术后均显示CD62P +血小板亚群增加(p<0.01)和sP-选择素浓度升高(p<0.001)。虽然肾切除术后sP-选择素浓度明显下降,但与对照组相比,术后3个月仍较高(p<0.05)。然而,肾切除术后,CD62P +血小板百分比和受体表达未发现统计学上的显著差异。在有局部淋巴结受累的患者(B组)中观察到肾切除术前和术后CD62P +血小板百分比(B1:B2 p<0.05)和受体表达(B1:B3 p<0.001)变化的动态更大,而两组中sP-选择素浓度相似。肾切除术未能使PLT的血管内活化正常化,TNM对CD62P的表达和sP-选择素的浓度没有显著影响。

相似文献

1
Effect of tumor stage and nephrectomy on CD62P expression and sP-selectin concentration in renal cancer.肿瘤分期和肾切除术对肾癌中CD62P表达及可溶性P选择素浓度的影响
Neoplasma. 2003;50(4):262-5.
2
Does renal carcinoma affect the expression of P-selectin on platelets?肾癌会影响血小板上P选择素的表达吗?
Neoplasma. 2002;49(4):243-5.
3
Changes in platelet CD 62P expression and soluble P-selectin concentration in surgically treated colorectal carcinoma.手术治疗的结直肠癌患者血小板CD 62P表达及可溶性P选择素浓度的变化
Adv Med Sci. 2006;51:304-8.
4
Soluble P-selectin concentration in patients with colorectal cancer.结直肠癌患者可溶性P选择素浓度
Neoplasma. 2005;52(4):297-301.
5
Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.血小板表面CD62P和CD63、平均血小板体积以及可溶性/血小板P-选择素作为心房颤动中血小板功能的指标:窦性心律下“健康对照受试者”与“疾病对照受试者”的比较
J Am Coll Cardiol. 2007 May 15;49(19):1957-64. doi: 10.1016/j.jacc.2007.02.038. Epub 2007 Apr 30.
6
Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.可溶性、血小板结合型及总P-选择素作为充血性心力衰竭中血小板活化的指标。
Ann Med. 2009;41(1):45-51. doi: 10.1080/07853890802227089.
7
The influence of hyperlipidemia on platelet activity markers in patients after ischemic stroke.高脂血症对缺血性脑卒中患者血小板活性标志物的影响。
Cerebrovasc Dis. 2009;27(2):131-7. doi: 10.1159/000177920. Epub 2008 Nov 28.
8
The origin of P-selectin as a circulating plasma protein.P-选择素作为循环血浆蛋白的起源。
Thromb Haemost. 1997 Jun;77(6):1081-5.
9
Platelet activation in acute, decompensated congestive heart failure.急性失代偿性充血性心力衰竭中的血小板活化
Thromb Res. 2007;120(5):709-13. doi: 10.1016/j.thromres.2007.01.003. Epub 2007 Feb 6.
10
Relationship between soluble P-selectin and inflammatory factors (interleukin-6 and C-reactive protein) in colorectal cancer.可溶性P-选择素与结直肠癌中炎症因子(白细胞介素-6和C反应蛋白)之间的关系
Thromb Res. 2007;120(4):585-90. doi: 10.1016/j.thromres.2006.11.002. Epub 2006 Dec 12.

引用本文的文献

1
Fast, streamlined fluorescence nanoscopy resolves rearrangements of SNARE and cargo proteins in platelets co-incubated with cancer cells.快速、流线型的荧光纳米技术解析了与癌细胞共孵育的血小板中 SNARE 和货物蛋白的重排。
J Nanobiotechnology. 2022 Jun 21;20(1):292. doi: 10.1186/s12951-022-01502-w.
2
Novel hematological biomarkers predict survival in renal cell carcinoma patients treated with nephrectomy.新型血液生物标志物可预测接受肾切除术治疗的肾细胞癌患者的生存率。
Arch Med Sci. 2017 Sep 21;16(5):1062-1071. doi: 10.5114/aoms.2017.70250. eCollection 2020.
3
The preoperative platelet distribution width: A predictive factor of the prognosis in patients with non-small cell lung cancer.
术前血小板分布宽度:预测非小细胞肺癌患者预后的指标。
Thorac Cancer. 2020 Apr;11(4):918-927. doi: 10.1111/1759-7714.13340. Epub 2020 Feb 15.
4
Novel Aspects of Extracellular Vesicles as Mediators of Cancer-Associated Thrombosis.细胞外囊泡作为癌症相关血栓形成的介质的新方面。
Cells. 2019 Jul 13;8(7):716. doi: 10.3390/cells8070716.
5
Impacts of Cancer on Platelet Production, Activation and Education and Mechanisms of Cancer-Associated Thrombosis.癌症对血小板生成、活化及驯化的影响以及癌症相关血栓形成的机制
Cancers (Basel). 2018 Nov 14;10(11):441. doi: 10.3390/cancers10110441.
6
Platelet RNA signatures for the detection of cancer.用于癌症检测的血小板RNA特征
Cancer Metastasis Rev. 2017 Jun;36(2):263-272. doi: 10.1007/s10555-017-9674-0.
7
Decreased platelet reactivity in patients with cancer is associated with high risk of venous thromboembolism and poor prognosis.癌症患者血小板反应性降低与静脉血栓栓塞的高风险和不良预后相关。
Thromb Haemost. 2017 Jan 5;117(1):90-98. doi: 10.1160/TH16-02-0123. Epub 2016 Oct 20.
8
Prognostic value of tumor growth factor levels during chemotherapy in patients with metastatic colorectal cancer.转移性结直肠癌患者化疗期间肿瘤生长因子水平的预后价值。
Med Oncol. 2012 Dec;29(5):3119-24. doi: 10.1007/s12032-012-0250-8. Epub 2012 May 12.